Michelangelo Rottura

Messina, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Influence of genetic polymorphisms on omalizumab clinical response in pediatric severe asthma: a pilot study.

Influence of genetic polymorphisms on omalizumab clinical response in pediatric severe asthma: a pilot study.

Journal: Frontiers in pharmacology

Published: April 16, 2026

Photoprotection habits and behaviors among Olympic-level rowers from four different countries: a cross-sectional study.

Photoprotection habits and behaviors among Olympic-level rowers from four different countries: a cross-sectional study.

Journal: Italian journal of dermatology and venereology

Published: April 16, 2026

Efficacy and Safety of Tirbanibulin 1% Ointment for Actinic Keratosis at 1-Year Follow-Up: A Real-Life Extension Study.

Efficacy and Safety of Tirbanibulin 1% Ointment for Actinic Keratosis at 1-Year Follow-Up: A Real-Life Extension Study.

Journal: Medicina (Kaunas, Lithuania)

Published: April 12, 2026

Post-marketing safety profile of dengue vaccines CYD-TDV and TAK-003: analysis of adverse event reports from a European database.

Post-marketing safety profile of dengue vaccines CYD-TDV and TAK-003: analysis of adverse event reports from a European database.

Journal: Frontiers in pharmacology

Published: January 16, 2026

Improving lipid-lowering treatment and cardiovascular risk management in primary care: findings from an audit and feedback project.

Improving lipid-lowering treatment and cardiovascular risk management in primary care: findings from an audit and feedback project.

Journal: Frontiers in pharmacology

Published: January 14, 2026

Efficacy of 5-Fluorouracil 4% Cream in the Treatment of Hyperkeratotic Actinic Keratosis: A Single-Center Retrospective Real-World Study.

Efficacy of 5-Fluorouracil 4% Cream in the Treatment of Hyperkeratotic Actinic Keratosis: A Single-Center Retrospective Real-World Study.

Journal: Dermatology and therapy

Published: July 04, 2025

Tirbanibulin 1% Ointment for the Treatment of Hyperkeratotic Actinic Keratosis.

Tirbanibulin 1% Ointment for the Treatment of Hyperkeratotic Actinic Keratosis.

Journal: The Journal of dermatology

Published: April 25, 2025

Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways.

Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 29, 2025

Genetic Polymorphisms on TNFA, TNFRSF1A, and TNFRSF1B Genes Predict the Effectiveness of Anti-TNF-α Treatment in Inflammatory Bowel Disease Patients.

Genetic Polymorphisms on TNFA, TNFRSF1A, and TNFRSF1B Genes Predict the Effectiveness of Anti-TNF-α Treatment in Inflammatory Bowel Disease Patients.

Journal: Biomedicines

Published: December 30, 2024

Proprotein convertase subtilisin/kexin type 9: a promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention.

Proprotein convertase subtilisin/kexin type 9: a promising marker of cardiovascular risk in post-menopausal diabetic women in primary prevention.

Journal: Frontiers in medicine

Published: November 01, 2024

The Skin-Lightening Power of Tirbanibulin 1% Ointment.

The Skin-Lightening Power of Tirbanibulin 1% Ointment.

Journal: Dermatology and therapy

Published: October 16, 2024

Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database.

Safety of Inclisiran: A Disproportionality Analysis from the EudraVigilance Database.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 18, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026